drugset / Trial / NCT01906190

Persistence of Immune Response After Vaccination With Influenza Vaccine

NCT01906190

NaSingle-groupOpen-labelPrevention

Summary

This clinical study will be performed in subjects aged 12-60 years old enrolled in NCT01310374 who received 2010 seasonal influenza vaccine to evaluate the persistence of the immune response of influenza vaccine up to 24 months after vaccination.

Timeline

Start
2011-08
Primary completion
2013-03
Completion
2013-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Quadrivalent influenza vaccine Vaccine

Indications